Cardiovascular outcome in systemic sclerosis

References

• Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009; 360:1989–2003.
   Google Scholar
• Smith V, Riccieri V. Pizzorni C, Decuman 5, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 2013; 40: 2023–8.
   Google Scholar
• Sebastiani M, Manfredi A, Colaci M, D’amico R, Malagoli V. Giuggioli D, Ferri C. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009; 61:688–94.
   Google Scholar
• Magne J, Lancellotti P. Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010; 122:33–41.
   Google Scholar
• Magne J, Lancellotti P. Piérard LA. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010; 56:300–9.
   Google Scholar
• Lancellotti P. Magne J, Donal E, O’Connor K, Dulgheru R, Rosca M, Pierard LA. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012; 126:851–9.
   Google Scholar
• Lancellotti P. Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005; 112(9 Suppl):1377–82.
   Google Scholar
• Alkotob ML, Soltani P. Sheatt MA, Katsetos MC, Rothfield N, Hager WD, Foley RJ, Silverman DI. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with sderoderma. Chest 2006; 130:176–81.
   Google Scholar
• Steen V, Chou M, Shanmugam V. Mathias M, Kuru T, Morrissey R. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008; 134:146–51.
   Google Scholar
• AllanoreY, Meune C. N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis. Clin Exp Rheumatol 2009; 27: 59–63.
   Google Scholar
• Gargani L, Pignone A, Agoston G, Moreo A, Capati E, Badano LP, Doveri M, Bazzichi L, Costantino MF, Pavellini A, Pieri F, Musca F, Muraru D, Epis O, Bruschi E, De Chiara B, Perfetto F, Mori F, Parodi O, Sicari R, Bombardieri 5, Varga A, Cerinic MM, Bossone E, Picano E. Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Am Heart J2013; 165:200–7.
   Google Scholar
• Argiento P. Chesler N, Mule M, D’Alto M, Bossone E, Unger P. Naeije R. Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J 2010 35: 1273–8.
   Google Scholar
• Argiento P, Vanderpool RR, Mule M, Russo MG, D’Alto M, Bossone E, Chesler NC, Naeije R. Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest 2012; 142:1158–65.
   Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon 5, Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr J2006; 7:79–108.
   Google Scholar
• Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corns P. Gaine 5, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J2009; 30:2493–537.
   Google Scholar
• Ngian GS, Sahhar J, Wicks IP, Van Doornum S. Cardiovascular disease in systemic sclerosis--an emerging association? Arthritis Res Ther 2011; 13:237.
   Google Scholar
• Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bulb o A, Cazzato M, urn E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri 5, Todesco S, Tirri G; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (51R-G555c). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139–53.
   Google Scholar
• Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010; 103: 46–52.
   Google Scholar
• loannidis JPA, Vlachoyiannopoulos PG, Haidich AB, Medsger, TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van LaarJM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118:2–10.
   Google Scholar
• Smith V, Decuman 5, SuIli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis 2012; 71: 1636–9.
   Google Scholar
• Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg 5, Galan P. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease. Atherosclerosis 2013; 228:478–84.
   Google Scholar
• MagneJ, Mahjoub H, Pierard LA, O’Connor K, Pirlet C, Pibarot P. Lancelloth P. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart 2012; 98:584–91.
   Google Scholar
• Roca M, Magne J, Cann A, Popescu BA, Piérard LA, Lancelloth P. Impact of aortic stiffness on left ventricular function and B-type natriuretic peptide release in severe aortic stenosis. Eur J Echocardiogr 2011; 12:850–6.
   Google Scholar
• Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P. Szturmowicz M. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006; 129:1313–21.
   Google Scholar
• Allanore Y, Borderie D, Meune C, Cabanes L, Weber 5, Ekindjian OG, Kahan A. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers. Arthritis Rheum 2003; 48: 3503–3508.
   Google Scholar
• Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006; 27: 1485–1494.
   Google Scholar
• Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber 5, Kahan A. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284–291.
   Google Scholar
• Allanore Y, Wahbi K, Borderie D, Weber 5, Kahan A, Meune C. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? Ann Rheum Dis 2009; 68: 1885–9.
   Google Scholar
• Steen VD, Follansbee WP, Conte CG, Medsger TA Jr.Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 1996; 39: 677–81.
   Google Scholar
• Gustafsson R, Mannting F, Kazzam E, Waldenström A, Höllgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989; 2:475–9.
   Google Scholar